Screener
AbCellera Biologics Inc. ABCL Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | December 31, 2025 | June 30, 2026 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable and other current liabilities | $50,781 | $32,484 |
| Deferred revenue | 13,526 | 20,705 |
| Total current liabilities | 64,307 | 53,189 |
| Long-term liabilities: | ||
| Operating lease liability | 137,403 | 129,948 |
| Deferred revenue | 3,500 | 40,450 |
| Deferred government contributions | 174,453 | 178,254 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s total current liabilities?
- AbCellera Biologics Inc. (ABCL) reported total current liabilities of $53.19M in Q2 2026.
- How has AbCellera Biologics Inc.'s total current liabilities changed year-over-year?
- AbCellera Biologics Inc.'s total current liabilities decreased by 20.6% year-over-year, from $67.02M to $53.19M.
- What is the long-term trend for AbCellera Biologics Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s total current liabilities has grown at a -9.1% compound annual growth rate (CAGR), from $103.49M to $64.31M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about AbCellera Biologics Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude